The DOI matches its Crossref record; 188 of the 188 references it cites were found in a registry or an index.
Preeclampsia, a Disease of the Maternal Endothelium: The Role of Antiangiogenic Factors and Implications for Later Cardiovascular Disease
Open accessAbstract
Preeclampsia is a clinical syndrome defined as the new onset of hypertension and proteinuria during the second half of pregnancy.1 It afflicts 3% to 5% of pregnancies and is a leading cause of maternal mortality, especially in developing countries.2,3 Because the only known remedy is delivery of the placenta, in developed countries preeclampsia is an important cause of premature delivery, usually medically indicated for the benefit of the mother. This results in infant morbidity and substantial healthcare expenditure.4 Despite the considerable morbidity and mortality, the cause of preeclampsia has remained enigmatic. Both hypertension and proteinuria implicate the endothelium as the target of the disease. The hypertension of preeclampsia is characterized by peripheral vasoconstriction and decreased arterial compliance.5,6 The proteinuria of preeclampsia is associated with a pathognomonic renal lesion known as glomerular endotheliosis, in which the endothelial cells of the glomerulus swell and endothelial fenestrations are lost.7,8 Podocyturia has been recently associated with preeclampsia during clinical disease9; however, whether this is the cause or effect of proteinuria is unknown. The glomerular filtration rate is decreased compared with normotensive pregnant women; in rare cases, acute renal failure may develop. Preeclampsia is a systemic vascular disorder that may also affect the liver and the brain in the mothers. When the liver is involved, women may present with abdominal pain, nausea, vomiting, and elevated liver enzymes. Pathological examination of the liver reveals periportal and sinusoidal fibrin deposition and, in more extreme cases, hemorrhage and necrosis.10 The severe preeclampsia variant HELLP syndrome (hemolysis, elevated liver enzymes, low platelets) occurs in ≈20% of women with severe preeclampsia,11 and is named not only for the liver involvement, but also for the disorder of the coagulation system that develops.12 Approximately 20% of …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Maynard, S. E., Min, J.-Y., Merchan, J., Lim, K.-H., Li, J., Mondal, S., Libermann, T. A., Morgan, J. P., Sellke, F. W., Stillman, I. E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17189 · Cited by 4,101
Self-citationFailure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931
Circulating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
Self-citationHeterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628
A Reversible Posterior Leukoencephalopathy Syndrome
Hinchey, J., Chaves, C., Appignani, B., Breen, J., Pao, L., Wang, A., Pessin, M. S., Lamy, C., Mas, J.-L., & Caplan, L. R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602223340803 · Cited by 3,340
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
Miller, K., Wang, M., Gralow, J., Dickler, M., Cobleigh, M., Perez, E. A., Shenkier, T., Cella, D., & Davidson, N. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072113 · Cited by 3,081
Yang, J. C., Haworth, L., Sherry, R. M., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Steinberg, S. M., Chen, H. X., & Rosenberg, S. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021491 · Cited by 2,697
Circulating angiogenic factors and the risk of preeclampsia*
(2004) · Obstetrics & Gynecology · doi:10.1097/00006250-200405000-00028 · Cited by 2,615
Cited by
Gestational Hypertension and Preeclampsia
(2020) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003891 · Cited by 2,949
Rana (2019) · doi:10.1161/circresaha.118.313276 · Cited by 2,095
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406
Pre-eclampsia: pathogenesis, novel diagnostics and therapies
Phipps, E. A., Thadhani, R., Benzing, T., & Karumanchi, S. A. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0119-6 · Cited by 1,191
Self-citation(2019) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003018 · Cited by 878
Mohammed, S. F., Hussain, S., Mirzoyev, S. A., Edwards, W. D., Maleszewski, J. J., & Redfield, M. M. (2015) · Circulation · doi:10.1161/circulationaha.114.009625 · Cited by 874
Cardiovascular Toxic Effects of Targeted Cancer Therapies
Moslehi, J. J. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1100265 · Cited by 635
Magee, L. A., Nicolaides, K. H., & von Dadelszen, P. (2022) · New England Journal of Medicine · doi:10.1056/nejmra2109523 · Cited by 546
Preeclampsia; short and long-term consequences for mother and neonate
Bokslag, A., van Weissenbruch, M., Mol, B. W., & de Groot, C. J. M. (2016) · Early Human Development · doi:10.1016/j.earlhumdev.2016.09.007 · Cited by 469
Arany, Z., & Elkayam, U. (2016) · Circulation · doi:10.1161/circulationaha.115.020491 · Cited by 403
High-Risk Cardiac Disease in Pregnancy
Elkayam, U., Goland, S., Pieper, P. G., & Silversides, C. K. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.05.048 · Cited by 370
Gestational Diabetes Mellitus: A Harbinger of the Vicious Cycle of Diabetes
Alejandro, E. U., Mamerto, T. P., Chung, G., Villavieja, A., Gaus, N. L., Morgan, E., & Pineda-Cortel, M. R. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145003 · Cited by 353
The Relationship Between Pre-Eclampsia and Peripartum Cardiomyopathy
Bello, N., Rendon, I. S. H., & Arany, Z. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.08.717 · Cited by 336
Rana, S., Burke, S. D., & Karumanchi, S. A. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.10.022 · Cited by 335
Self-citationPre-Eclampsia and Future Cardiovascular Risk Among Women
Ahmed, R., Dunford, J., Mehran, R., Robson, S., & Kunadian, V. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.529 · Cited by 324
Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia
Chen, J., & Khalil, R. A. (2017) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2017.04.001 · Cited by 274
Long-Term Cardiovascular Risks Associated With Adverse Pregnancy Outcomes
Lane-Cordova, A. D., Khan, S. S., Grobman, W. A., Greenland, P., & Shah, S. J. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.12.092 · Cited by 269
Pathophysiology and epidemiology of peripartum cardiomyopathy
Hilfiker-Kleiner, D., & Sliwa, K. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.37 · Cited by 252
Brownfoot, F. C., Hastie, R., Hannan, N. J., Cannon, P., Tuohey, L., Parry, L. J., Senadheera, S., Illanes, S. E., Kaitu’u-Lino, T. J., & Tong, S. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.12.019 · Cited by 222
Adverse pregnancy outcomes and future maternal cardiovascular disease
Hauspurg, A., Ying, W., Hubel, C. A., Michos, E. D., & Ouyang, P. (2018) · Clinical Cardiology · doi:10.1002/clc.22887 · Cited by 179
“Finally, the distinct possibility that preeclampsia generates lasting endothelial dysfunction and causes the increased risk of CVD cannot be overlooked.(15) Prior studies have shown that the endothelial dysfunction in women with preeclampsia persists into the postpartum period, suggesting a possible mechanism for the…”
BackgroundAngiogenic Factors in Preeclampsia: From Diagnosis to Therapy
Karumanchi, S. A. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.06421 · Cited by 163
Self-citationMasoudian, P., Nasr, A., de Nanassy, J., Fung-Kee-Fung, K., Bainbridge, S. A., & El Demellawy, D. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.11.020 · Cited by 157
Wang, Z., Wang, P., Liu, H., He, X., Zhang, J., Yan, H., Xu, D., & Wang, B. (2013) · Obesity Reviews · doi:10.1111/obr.12025 · Cited by 111
Hypertensive Disorders of Pregnancy and Offspring Cardiac Structure and Function in Adolescence
Timpka, S., Macdonald‐Wallis, C., Hughes, A. D., Chaturvedi, N., Franks, P. W., Lawlor, D. A., & Fraser, A. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003906 · Cited by 106
“A complex syndrome of suboptimal placentation, increased levels of antiangiogenic factors, and fetal hypoxia, preeclampsia is associated with significant mortality and morbidity in mothers and offspring.(2,3) No definite cure other than delivery is known.”
Ambient air pollution and hypertensive disorders of pregnancy: A systematic review and meta-analysis
Hu, H., Ha, S., Roth, J., Kearney, G., Talbott, E. O., & Xu, X. (2014) · Atmospheric Environment · doi:10.1016/j.atmosenv.2014.08.027 · Cited by 105
Erickson, A. C., & Arbour, L. (2014) · Journal of Environmental and Public Health · doi:10.1155/2014/901017 · Cited by 90
Sequential plasma angiogenic factors levels in women with suspected preeclampsia
Baltajian, K., Bajracharya, S., Salahuddin, S., Berg, A. H., Geahchan, C., Wenger, J. B., Thadhani, R., Karumanchi, S. A., & Rana, S. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.01.168 · Cited by 88
Self-citationSchliep, K. C., Mclean, H., Yan, B., Qeadan, F., Theilen, L. H., de Havenon, A., Majersik, J. J., Østbye, T., Sharma, S., & Varner, M. W. (2023) · Hypertension · doi:10.1161/hypertensionaha.122.19399 · Cited by 69
Pereira, G., Haggar, F., Shand, A. W., Bower, C., Cook, A., & Nassar, N. (2013) · Journal of Epidemiology and Community Health · doi:10.1136/jech-2011-200805 · Cited by 68
“26 Although the underlying cause(s) of pre-eclampsia are not known, one of the leading mechanisms identified in relation to pre-eclampsia is endothelial dysfunction resulting in abnormal placentation and failed vascular remodelling followed by hyperinflammation and endothelial activation which may trigger the maternal…”
BackgroundOh, Y. S., Appel, L. J., Galis, Z. S., Hafler, D. A., He, J., Hernandez, A. L., Joe, B., Karumanchi, S. A., Maric-Bilkan, C., Mattson, D., et al. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07415 · Cited by 52
Self-citationPreterm birth and cardiac function in adulthood
Greer, C., Troughton, R. W., Adamson, P. D., & Harris, S. L. (2022) · Heart · doi:10.1136/heartjnl-2020-318241 · Cited by 29
Angiogenic and antiangiogenic markers for prediction and risk classification of preeclampsia
MALSHE, A. K., & SIBAI, B. M. (2017) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000267 · Cited by 18
Feng, Y., Drzymalski, D., Zhao, B., Wang, X., & Chen, X. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-1914-y · Cited by 9
Metadata
- Authors
- Powe, C. E., Levine, R. J., & Karumanchi, S. A.
- Venue
- Circulation
- Published
- 2011-06-21
- Volume
- 123
- Issue
- 24
- Pages
- 2856-2869
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2017904618
- Cited by
- 967
- References
- 188
- FWCI
- 54.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.